AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 64 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,185,000 | +912.8% | 515,133 | +1999.6% | 0.00% | – |
| Q4 2021 | $117,000 | -36.8% | 24,535 | +5.6% | 0.00% | – |
| Q3 2021 | $185,000 | +10.8% | 23,243 | -3.1% | 0.00% | – |
| Q2 2021 | $167,000 | -31.3% | 23,993 | -21.9% | 0.00% | – |
| Q1 2021 | $243,000 | -7.6% | 30,718 | -8.2% | 0.00% | – |
| Q4 2020 | $263,000 | -43.4% | 33,463 | -49.0% | 0.00% | – |
| Q3 2020 | $465,000 | -20.9% | 65,559 | +3.2% | 0.00% | – |
| Q2 2020 | $588,000 | +147.1% | 63,523 | +24.5% | 0.00% | – |
| Q1 2020 | $238,000 | -51.0% | 51,003 | -20.0% | 0.00% | – |
| Q4 2019 | $486,000 | +817.0% | 63,769 | +805.3% | 0.00% | – |
| Q3 2019 | $53,000 | -53.9% | 7,044 | -58.4% | 0.00% | – |
| Q2 2019 | $115,000 | -37.2% | 16,942 | -25.8% | 0.00% | – |
| Q1 2019 | $183,000 | +28.0% | 22,845 | +19.0% | 0.00% | – |
| Q4 2018 | $143,000 | -78.6% | 19,204 | -72.6% | 0.00% | – |
| Q3 2018 | $669,000 | -82.7% | 70,142 | -80.8% | 0.00% | -100.0% |
| Q2 2018 | $3,868,000 | +386700.0% | 365,697 | +71605.3% | 0.00% | – |
| Q2 2017 | $1,000 | -97.2% | 510 | -89.7% | 0.00% | – |
| Q1 2017 | $36,000 | +800.0% | 4,959 | +436.1% | 0.00% | – |
| Q2 2016 | $4,000 | – | 925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 340,679 | $3,604,000 | 1.39% |
| Nantahala Capital Management | 2,213,052 | $23,414,000 | 0.95% |
| SCP Investment, LP | 156,137 | $1,652,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 509,118 | $5,386,000 | 0.74% |
| DELTEC ASSET MANAGEMENT LLC | 151,781 | $1,606,000 | 0.32% |
| Rock Springs Capital Management LP | 650,000 | $6,877,000 | 0.26% |
| Orbimed Advisors | 1,865,524 | $19,737,000 | 0.24% |
| Baker Brothers Advisors | 1,387,872 | $14,684,000 | 0.11% |
| EAM Investors, LLC | 56,726 | $600,000 | 0.10% |
| Stanley-Laman Group, Ltd. | 35,036 | $371,000 | 0.08% |